• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS CHEMISTRY PRODUCTS CREA SLIDES; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS CHEMISTRY PRODUCTS CREA SLIDES; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 6802584
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/23/2018
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that reproducible, lower than expected vitros crea results were obtained from a single patient sample when processed on a vitros 5600 integrated system, when compared to the result obtained from a non-vitros roche method.The investigation was unable to determine a definitive assignable cause.However, since the issue was isolated to a single patient sample, an unknown sample interferent that affects the vitros assay, but not the non-vitros roche method, is the likely cause of the event, but this could not be confirmed.There was no indication the vitros 5600 integrated system malfunctioned, however, since no within-run precision performance testing was processed, an instrument related issue cannot be completely ruled out as contributing to the event.Additionally, the historical quality control data review indicates the vitros crea slides were performing as intended and did not likely contribute to the event.A definitive assignable cause for the event could not be determined.
 
Event Description
A customer obtained reproducible, lower than expected vitros creatinine (crea) results from a single patient sample tested on a vitros 5600 integrated system, when compared to the result obtained from a non-vitros roche method.Vitros crea results of 0.56 and 0.46 mg/dl vs.The expected result of 3.45 mg/dl.Biased results of the magnitude and direction observed may lead to inappropriate physician action if the event were to occur undetected.The lower than expected crea results were not reported outside the laboratory and there were no reported allegations of actual patient harm as a result of this event.This report corresponds to ortho clinical diagnostics (ortho) inc.Complaint numbers (b)(4) / qerts record id (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS CHEMISTRY PRODUCTS CREA SLIDES
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO-CLINICAL DIAGNOSTICS
513 technology blvd.
rochester NY 14652
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key7716248
MDR Text Key115673948
Report Number1319809-2018-00100
Device Sequence Number1
Product Code JFY
Combination Product (y/n)N
Reporter Country CodeSP
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Other
Type of Report Initial
Report Date 07/24/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/24/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/01/2019
Device Catalogue Number6802584
Device Lot Number1515-3474-6084
Was Device Available for Evaluation? Yes
Date Manufacturer Received06/27/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/08/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-